glp-1 weight loss rate Trends The GLP-1 Access Gap: Mapping

Pharmacokinetics: Bioavailability: ~90% Half-life: ~2430 hours Metabolism: Minimal hepatic metabolism Excretion: Mainly renal Adverse Effects: Headache Nausea Abdominal pain Diarrhea Interesting Fact: Unlike older prokinetic agents (like cisapride), prucalopride has high receptor selectivity, reducing the risk of cardiac arrhythmias a major safety improvement

The changes could give doctors more flexibility to choose diabetes drugs based on patients heart, kidney and other risks rather than a fixed sequence of older medicines

In two studies with adults who had obesity and moderate to severe OSA over a 52-week period, participants who received Zepbound experienced a "statistically significant and clinically meaningful reduction" in episodes of shallow breathing or temporary pauses in breathing while asleep compared to those who received a placebo, the FDA said

When GLP-1 medications slow movement through an already-inflamed bowel, the combined effect could theoretically worsen symptoms like abdominal pain, diarrhea, or obstruction risk

If true, it means brain health benefits

What they do is bring an out-of-control appetite back into a more normal range so people can make healthier choices